{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T23:33:33Z","timestamp":1693006413733},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/jcp.0b013e31820f4f9e","type":"journal-article","created":{"date-parts":[[2011,3,2]],"date-time":"2011-03-02T19:30:37Z","timestamp":1299094237000},"page":"242-243","source":"Crossref","is-referenced-by-count":7,"title":["Rapid Development of Severe Hypertriglyceridemia and Hypercholesterolemia During Augmentation of Quetiapine With Valproic Acid"],"prefix":"10.1097","volume":"31","author":[{"given":"Chih-Sung","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Mao","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210128","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/JCP.0b013e318166c4f7","article-title":"Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.","volume":"28","author":"Birkenaes","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R2-21-20210128","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","article-title":"Proposal for a new tool to evaluate drug interaction cases.","volume":"41","author":"Horn","year":"2007","journal-title":"Ann Pharmacother"},{"key":"R3-21-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.yic.0000188213.46667.f1","article-title":"Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations.","volume":"21","author":"Aichhorn","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R4-21-20210128","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/YIC.0b013e32832d6c18","article-title":"Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a veterans affairs population.","volume":"24","author":"Duncan","year":"2009","journal-title":"Int Clin Psychopharmacol"},{"key":"R5-21-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2007.01.015","article-title":"A clinical study of the association of antipsychotics with hyperlipidemia.","volume":"92","author":"de Leon","year":"2007","journal-title":"Schizophr Res"},{"key":"R6-21-20210128","first-page":"MT50","article-title":"The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.","volume":"10","author":"Nikolaos","year":"2004","journal-title":"Med Sci Monit"},{"key":"R7-21-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(00)00119-4","article-title":"The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.","volume":"41","author":"Eiris","year":"2000","journal-title":"Epilepsy Res"},{"key":"R8-21-20210128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1345\/aph.1L414","article-title":"Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.","volume":"43","author":"Grosso","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R9-21-20210128","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.jcp.0000264989.63227.82","article-title":"Cervical dystonia due to interaction of valproic acid and quetiapine.","volume":"27","author":"Habermeyer","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R10-21-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-3223(01)01333-6","article-title":"Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin.","volume":"51","author":"Furst","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R11-21-20210128","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SMJ.0b013e31804b1e4d","article-title":"New onset diabetes with ketoacidosis attributed to quetiapine.","volume":"100","author":"Marlowe","year":"2007","journal-title":"South Med J"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e31820f4f9e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:59:10Z","timestamp":1620957550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201104000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31820f4f9e","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}